A new trading day began on Tuesday, with FibroGen Inc (NASDAQ: FGEN) stock price down -5.65% from the previous day of trading, before settling in for the closing price of $0.33. FGEN’s price has ranged from $0.29 to $2.93 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -2.51% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 65.03%. With a float of $93.37 million, this company’s outstanding shares have now reached $98.77 million.
In an organization with 486 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 76.65%, operating margin of -91.86%, and the pretax margin is -98.64%.
FibroGen Inc (FGEN) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of FibroGen Inc is 7.00%, while institutional ownership is 57.17%. The most recent insider transaction that took place on Jun 12 ’24, was worth 25,884. In this transaction Chief Medical Officer of this company bought 22,123 shares at a rate of $1.17, taking the stock ownership to the 82,123 shares. Before that another transaction happened on Mar 07 ’24, when Company’s CEO bought 50,000 for $1.91, making the entire transaction worth $95,470. This insider now owns 470,178 shares in total.
FibroGen Inc (FGEN) Performance Highlights and Predictions
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -0.65 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.22 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 65.03% per share during the next fiscal year.
FibroGen Inc (NASDAQ: FGEN) Trading Performance Indicators
Here are FibroGen Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.18.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.71, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -0.69 in one year’s time.
Technical Analysis of FibroGen Inc (FGEN)
Let’s dig in a bit further. During the last 5-days, its volume was 0.96 million. That was inferior than the volume of 2.24 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 40.26%. Additionally, its Average True Range was 0.03.
During the past 100 days, FibroGen Inc’s (FGEN) raw stochastic average was set at 1.61%, which indicates a significant decrease from 17.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 70.05% in the past 14 days, which was lower than the 140.05% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3710, while its 200-day Moving Average is $1.0970. However, in the short run, FibroGen Inc’s stock first resistance to watch stands at $0.3267. Second resistance stands at $0.3433. The third major resistance level sits at $0.3567. If the price goes on to break the first support level at $0.2967, it is likely to go to the next support level at $0.2833. Assuming the price breaks the second support level, the third support level stands at $0.2667.
FibroGen Inc (NASDAQ: FGEN) Key Stats
With a market capitalization of 30.82 million, the company has a total of 100,401K Shares Outstanding. Currently, annual sales are 147,750 K while annual income is -284,230 K. The company’s previous quarter sales were 50,640 K while its latest quarter income was -15,540 K.
